Arca
Skip to content

Memory Disorders

Drug research and approvals for memory Disorders: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 232 studies of memory Disorders are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 232
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 232 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

5 in phase 3, 6 in phase 2, 3 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Celecoxib
Phase 3 Cyclooxygenase-2 inhibitor
Progesterone
Phase 3 Progesterone receptor agonist
Estrogens, conjugated
Phase 3 Estrogen receptor agonist
Ginkgo
Phase 3
Estrogen
Phase 3
Albuterol
Phase 2 Beta-2 adrenergic receptor agonist
Vilazodone
Phase 2 Serotonin transporter inhibitor
Cinacalcet
Phase 2 Calcium sensing receptor positive allosteric modulator
Ispronicline
Phase 2 Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
HT-0712
Phase 2 Phosphodiesterase 4 inhibitor
Nicotine
Phase 1 Neuronal acetylcholine receptor; alpha4/beta2 agonist
Minocycline
Phase 1 Bacterial 70S ribosome inhibitor
Leteprinim
Phase 1

How Its Trials Ended

201 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 40 whose ending is known, 35% met their primary endpoint, 25% missed it and 40% stopped early.

  • Completed, result not reported9447%
  • Ongoing4321%
  • Status unknown2412%
  • Met its primary endpoint147%
  • Missed its primary endpoint105%
  • Stopped: other or unclear94%
  • Stopped: enrollment or feasibility73%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.